UK Validation of the Automated "AcceXible" Speech Analysis Software

Last updated: September 7, 2022
Sponsor: Accexible
Overall Status: Active - Recruiting

Phase

N/A

Condition

Dementia

Memory Problems

Mild Cognitive Impairment

Treatment

N/A

Clinical Study ID

NCT05534958
AcceXible-Healthy,MCI,Dementia
  • Ages 55-90
  • All Genders

Study Summary

Dementia, especially dementia caused by Alzheimer's disease, is considered one of the most severe health problems of our time. It is currently known that the disease begins many years before clinical symptoms appear. The sooner the patient is diagnosed, the sooner the patient will be in a position to prevent further deterioration.

A recent orientation is the analysis of language in relation to the description of images with a high and varied semantic and emotional content. It can be studied that changes in the description of an image check if these changes are associated with the evolution of a person with probable impairment both in memory and cognitive as well as emotional, psychiatric, behavioral and even in their interaction with environmental factors especially those associated with socialization and loneliness.

The present study has the objective of validating a digital method for detection and follow-up of patients with mild cognitive impairment (MCI) or dementia in a memory clinic setting.

Eligibility Criteria

Inclusion

Inclusion Criteria for patients:

  • Adult patients 55+ years of age with suspected MCI or diagnosis of dementia referred into secondary care memory clinic by their General Practitioner.

  • Have English as first language (able to speak and understand verbal messages).

  • Patients must have agreed to participate in the study and have voluntarily signed the informed consent.

Inclusion Criteria for healthy volunteers:

  • Healthy older adults (55+ years of age), without a diagnosis neurological, or psychiatric disorders or any clinical evidence of cognitive decline.

  • Have English as first language (able to speak and understand verbal messages).

  • Controls must have agreed to participate in the study and have voluntarily signed the informed consent.

Exclusion Criteria for patients:

  • To have received a diagnosis of a significant psychiatric disorder or other cognitive impairment not due to neurodegeneration.

  • To have significant vision problems that would affect the ability to perceive visual stimuli.

  • To have significant hearing problems that would affect the ability to understand verbal cues.

  • To be unable to give informed consent to participate in the study.

Exclusion Criteria for healthy volunteers:

  • Objective evidence of significant cognitive decline in any one domain.

  • Score of <88 on ACE-III cognitive testing.

Study Design

Total Participants: 248
Study Start date:
August 01, 2022
Estimated Completion Date:
December 31, 2023

Connect with a study center

  • Cornwall Partnership NHS Foundation Trust

    Cornwell,
    United Kingdom

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.